Coherus BioSciences (CHRS) Defended at Citi, Analyst Says Buy Weakness - Bloomberg
- Wall Street again marks new highs in post-election run
- Broadcom Ltd. (AVGO) Tops Q4 EPS by 11c
- Restoration Hardware (RH) Tops Q3 EPS by 4c; Guides Well Below the Street
- Unusual 11 Mid-Day Movers 12/8: (COOL) (TLRD) (DRAM) Higher; (SHIP) (OHRP) (MLSS) Lower
- After-Hours Stock Movers 12/08: (FNSR) (AVGO) (GLPG) Higher; (XTLY) (RH) (DLTH) Lower (more...)
Get instant alerts when news breaks on your stocks. Claim your 2-week free trial to StreetInsider Premium here.
Coherus BioSciences (NASDAQ: CHRS) Defended at Citi, Analyst Says Buy Weakness - Bloomberg
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- BMO Capital Reiterates Outperform on Costco Wholesale (COST) Following 1Q Report
- SunTrust Analyst Bob Peck Leaving to Join Credit Suisse
- Stifel Reiterates Buy on Casella Waste Systems (CWST) - PT to $16
Create E-mail Alert Related CategoriesAnalyst Comments, Hot Comments, Trader Talk
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!